Lionco Pharmaceutical Group Co (SHSE:603669) Inventories, Raw Materials & Components: ¥0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603669 Lionco Pharmaceutical Group Co Ltd SHSE:603669
48 GF Score
Price ¥7.30
GF Value ¥6.82
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Lionco Pharmaceutical Group Co Inventories, Raw Materials & Components?

Lionco Pharmaceutical Group Co SHSE:603669 -9.99% 48 Inventories, Raw Materials & Components is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SHSE:603669 with a GF Score™ of 48/100 and a GF Value™ of ¥6.82 (Fairly Valued). The stock has 6 warning signs investors should review.

Lionco Pharmaceutical Group Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ¥0.0 Mil.

Lionco Pharmaceutical Group Co's quarterly raw materials increased from Sep. 2025 (¥0.0 Mil) to Dec. 2025 (¥9.3 Mil) but then declined from Dec. 2025 (¥9.3 Mil) to Mar. 2026 (¥0.0 Mil).

Lionco Pharmaceutical Group Co's annual raw materials declined from Dec. 2023 (¥19.1 Mil) to Dec. 2024 (¥11.2 Mil) and declined from Dec. 2024 (¥11.2 Mil) to Dec. 2025 (¥9.3 Mil).

Lionco Pharmaceutical Group Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Lionco Pharmaceutical Group Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lionco Pharmaceutical Group Co Inventories, Raw Materials & Components Chart

Lionco Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.00 18.90 19.08 11.25 9.25

Lionco Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 13.13 0.00 9.25 0.00
SHSE:603669
48GF Score
Lionco Pharmaceutical Group Co Ltd SHSE:603669
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lionco Pharmaceutical Group Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ¥0.0 Mil mean?
Lionco Pharmaceutical Group Co (SHSE:603669) has a Inventories, Raw Materials & Components of ¥0.0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Lionco Pharmaceutical Group Co and its competitors.
Is Lionco Pharmaceutical Group Co's Inventories, Raw Materials & Components too high?
Lionco Pharmaceutical Group Co's current Inventories, Raw Materials & Components is ¥0.0 Mil. Overall, Lionco Pharmaceutical Group Co has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Lionco Pharmaceutical Group Co's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Lionco Pharmaceutical Group Co's Inventories, Raw Materials & Components of ¥0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Lionco Pharmaceutical Group Co and its competitors. Lionco Pharmaceutical Group Co's current Inventories, Raw Materials & Components is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lionco Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co (SHSE:603669) is currently considered Fairly Valued. The stock's GF Value™ is ¥6.82, compared to a current price of ¥7.30 — trading 7% above its estimated fair value. The current Inventories, Raw Materials & Components is ¥0.0 Mil. Lionco Pharmaceutical Group Co's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Lionco Pharmaceutical Group Co (SHSE:603669), the current Inventories, Raw Materials & Components is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lionco Pharmaceutical Group Co (SHSE:603669) Overvalued in 2026?

Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥7.30 is trading 7% above its estimated GF Value™ of ¥6.82. GuruFocus considers Lionco Pharmaceutical Group Co to be Fairly Valued.

Key valuation signals for SHSE:603669:

  • Inventories, Raw Materials & Components: ¥0.0 Mil
  • GF Value™: ¥6.82 vs. price of ¥7.30 (7% above fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lionco Pharmaceutical Group Co Business Description

Address No. 20, National Highway 349, Naidong District, Shannan, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
48GF Score

Get the complete analysis for SHSE:603669

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.30
Price
¥6.82
GF Value